175 related articles for article (PubMed ID: 16485696)
1. Comparison of ACT point-of-care measurements: repeatability and agreement.
Bosch YP; Ganushchak YM; de Jong DS
Perfusion; 2006 Jan; 21(1):27-31. PubMed ID: 16485696
[TBL] [Abstract][Full Text] [Related]
2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
Dirkmann D; Nagy E; Britten MW; Peters J
BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
[TBL] [Abstract][Full Text] [Related]
4. Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution.
Lee JM; Park EY; Kim KM; Won JC; Jung TK; Lee SK
J Int Med Res; 2018 Feb; 46(2):873-882. PubMed ID: 28974132
[TBL] [Abstract][Full Text] [Related]
5. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
6. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.
Welsby IJ; McDonnell E; El-Moalem H; Stafford-Smith M; Toffaletti JG
J Clin Monit Comput; 2002 Jul; 17(5):287-92. PubMed ID: 12546261
[TBL] [Abstract][Full Text] [Related]
7. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec ACT and Hemochron Jr apparatus.
Svenmarker S; Appelblad M; Jansson E; Häggmark S
Perfusion; 2004; 19(5):289-94. PubMed ID: 15506033
[TBL] [Abstract][Full Text] [Related]
9. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
Chia S; Van Cott EM; Raffel OC; Jang IK
Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
[TBL] [Abstract][Full Text] [Related]
10. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
[TBL] [Abstract][Full Text] [Related]
11. Interchangeability of activated clotting time values across different point-of-care systems.
Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
[TBL] [Abstract][Full Text] [Related]
12. Point-of-Care Measurement of Kaolin Activated Clotting Time during Cardiopulmonary Bypass: A Single Sample Comparison between ACT Plus and i-STAT.
Vranken NPA; Theelen AJAJ; Orbons T; Barenbrug PJC; Weerwind PW
J Extra Corpor Technol; 2021 Mar; 53(1):57-61. PubMed ID: 33814607
[TBL] [Abstract][Full Text] [Related]
13. New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron.
Aylsworth CL; Stefan F; Woitas K; Rieger RH; LeBoutillier M; DiSesa VJ
Ann Thorac Surg; 2004 Mar; 77(3):973-6. PubMed ID: 14992909
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
[TBL] [Abstract][Full Text] [Related]
15. Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological intervention.
Kubalek R; Berlis A; Schwab M; Klisch J; Schumacher M
Neuroradiology; 2003 May; 45(5):325-7. PubMed ID: 12669158
[TBL] [Abstract][Full Text] [Related]
16. Reliability of point-of-care hematocrit, blood gas, electrolyte, lactate and glucose measurement during cardiopulmonary bypass.
Steinfelder-Visscher J; Weerwind PW; Teerenstra S; Brouwer MH
Perfusion; 2006 Jan; 21(1):33-7. PubMed ID: 16485697
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass.
Li H; Serrick C; Rao V; Yip PM
Perfusion; 2021 Sep; 36(6):610-619. PubMed ID: 32885714
[TBL] [Abstract][Full Text] [Related]
18. Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices.
Falter F; Razzaq N; John M; Fassl J; Maurer M; Ewing S; Hofmeyr R
J Extra Corpor Technol; 2018 Mar; 50(1):38-43. PubMed ID: 29559753
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory.
Doherty TM; Shavelle RM; French WJ
Catheter Cardiovasc Interv; 2005 Jul; 65(3):330-7. PubMed ID: 15864806
[TBL] [Abstract][Full Text] [Related]
20. The activated clotting time in cardiac surgery: should Celite or kaolin be used?
De Vries AJ; Lansink-Hartgring AO; Fernhout FJ; Huet RCG; van den Heuvel ER
Interact Cardiovasc Thorac Surg; 2017 Apr; 24(4):549-554. PubMed ID: 28108578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
